Showing results (21-30 of 70) with videos related to
Sort By:
Pageof 7
Pediatric Blood & Cancer|July 21, 2017
Complications preceding early deaths in Black and White children with acute myeloid leukemiaLena E Winestone, Kelly D Getz, Tamara P Miller, et al.Cancer|April 30, 2025
Impact of neighborhood archetypes on overall mortality among young patients with acute leukemia in CaliforniaLena E Winestone, Juan Yang, Tanushree Banerjee, et al.Leukemia & Lymphoma|February 9, 2019
Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollmentLena E Winestone, Kelly D Getz, Pooja Rao, et al.Pediatric Blood & Cancer|November 15, 2019
The impact of total body irradiation-based regimens on outcomes in children and young adults with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantationBrian D Friend, Mara Bailey-Olson, Alexis Melton, et al.JCO Oncology Practice|October 22, 2020
Impact of Dependent Coverage Provision of the Affordable Care Act on Insurance Continuity for Adolescents and Young Adults With CancerLena E Winestone, Lauren L Hochman, James E Sharpe, et al.Cancer|January 27, 2025
Historical redlining and survival among children, adolescents, and young adults with cancer diagnosed between 2000-2019 in Seattle and Tacoma, WashingtonKristine A Karvonen, David R Doody, Dwight Barry, et al.Pediatric Blood & Cancer|March 7, 2022
A pilot trial of prophylactic defibrotide to prevent serious thrombotic microangiopathy in high-risk pediatric patientsChristine S Higham, Kristin A Shimano, Alexis Melton, et al.JCO Oncology Practice|August 22, 2020
Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic MalignanciesJennifer J Wilkes, Gary H Lyman, David R Doody, et al.Leukemia & Lymphoma|December 7, 2020
Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrolleesEric J Chow, David R Doody, Jennifer J Wilkes, et al.Transplantation and Cellular Therapy|December 1, 2021
Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in ChildrenFederica Forlanini, Matt S Zinter, Christopher C Dvorak, et al.Pageof 7